Neuphoria Therapeutics Inc
NEUP3.890USD
0.000
Close 12/19, 16:00（ET）Quotes delayed by 15 min
9.17MMarket Cap
LossP/E TTM
Neuphoria Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
15.65M
--
EPS(YoY)
-0.23
-120.19%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2025 earnings report, its total revenue reached 15.65M, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.228, with a year-on-year change of -120.19%.
What is the net income of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2025 earnings report, its net income was -369.63K, with a year-on-year change of 97.61%.
What is the net margin of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2025 earnings report, its net profit margin was -2.36%, with a year-on-year change of --.
What is the gross margin of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2025 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 0.11%, with a year-on-year change of -4.37%.
What is the Return on Equity (ROE) of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -2.03%, with a year-on-year change of 97.42%.
What is the Return on Assets (ROA) of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -1.31%, with a year-on-year change of 97.62%.
What is the operating profit of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2025 earnings report, its operating profit was -829.19K, with a year-on-year change of 95.34%.
What are the current assets of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2025 earnings report, its current assets were 15.04M, with a year-on-year change of 14.00%.
What are the total assets of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2025 earnings report, its total assets of Neuphoria Therapeutics Inc were 28.59M, with a year-on-year change of 3.40%.
What are the total liabilities of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2025 earnings report, its total liabilities of Neuphoria Therapeutics Inc were 9.59M, with a year-on-year change of -5.63%.
What is the total equity of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2025 earnings report, its total equity of Neuphoria Therapeutics Inc was 19.00M, with a year-on-year change of 8.65%.
What is the net operating income of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2025 earnings report, its net operating income of Neuphoria Therapeutics Inc was -369.63K, with a year-on-year change of 97.61%.
What is the net investment of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2025 earnings report, its net investment of Neuphoria Therapeutics Inc was --, with a year-on-year change of --.
What is the net financing of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2025 earnings report, its net financing of Neuphoria Therapeutics Inc was 1.53M, with a year-on-year change of -89.88%.
